A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Conditions: Soft Tissue Sarcoma; Renal Cell Carcinoma; Uterine Carcinosarcoma; Hepatocellular Carcinoma; Head and Neck Squamous Cell Carcinoma Intervention: Drug: HFB301001 Sponsor: HiFiBiO Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2022 Category: Research Source Type: clinical trials
Nivolumab for Recurrent/Metastatic Carcinosarcoma
Condition: Recurrent/Metastatic Carcinosarcoma Intervention: Drug: nivolumab Sponsor: Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials